How Do was paid
$1.4M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Total |
|---|---|---|---|---|
| Cuong DoChief Executive Officer and President | $640,000 | $96,000 | $653,990 | $1,389,990 |
| Joanne Wendy KimChief Financial Officer and Corporate Secretary | $350,000 | $39,375 | $108,228 | $497,603 |
| Joseph PalumboChief Medical Officer | $580,000 | $65,250 | $129,756 | $775,006 |
What changed and why
- $1.4M$1,389,990 CEO total compensation in 2026 increased from $860,149 in 2025.
- $654K$653,990 CEO option awards were the largest component of 2026 CEO compensation.
- $640K$640,000 CEO salary and $96,000 bonus were reported for 2026.
- $775K$775,006 total compensation was reported for Chief Medical Officer Joseph Palumbo.
- 939,090 stock options were held by the NEOs as of June 30, 2026.
- No termination or change-in-control payment arrangements existed for the named executives.
Other Biovie proxy statements
- 2025 proxy statement
Cuong Do paid $860,149 (+11% on the year).
Filed Sep 25, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.